{"url_path":"/sec/imrx/8-k/2026-05-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1790340/0001790340-26-000055-index.html","accession_number":"0001790340-26-000055","cik":"0001790340","ticker":"IMRX","issuer_name":"Immuneering Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1790340/0001790340-26-000055-index.html","primary_entity_key":"0001790340","primary_entity_name":"Immuneering Corp"},"word_count":102,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d)Exhibits\n\nThe following exhibits relate to Item 2.02, which shall be deemed to be furnished, and not filed:\n\nExhibit\nNo.Description\n\n99.1\n[Press Release issued on May](imrx-20260505xexx991.htm)[1](imrx-20260505xexx991.htm)[5, 2026](imrx-20260505xexx991.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nIMMUNEERING CORPORATION\n\nDate: May 15, 2026\nBy: /s/ Benjamin J. Zeskind\n\nName: Benjamin J. Zeskind, Ph.D.\n\nTitle: Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer)"}